Tariffs present ‘significant issues for pharmaceutical manufacturers’

Eli Lilly (LLY) stock is sinking as investors react to concerns around GLP-1 drugs and industry dynamics. Red Brook Advisors managing partner Syed Husain joins Catalysts to discuss the market moves and explain why markets may be overreacting.

To watch more expert insights and analysis on the latest market action, check out more Catalysts here: finance.yahoo.com/videos/series/catalysts/
#youtube #pharma #tariffs

About Yahoo Finance:

Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.

Get the latest news and data at finance.yahoo.com

Download the Yahoo Finance app on Apple (apple.co/3Rten0R) or Android (bit.ly/3t8UnXO)

Follow Yahoo Finance on social:

X: twitter.com/YahooFinance
Instagram: www.instagram.com/yahoofinance/?hl=en
TikTok: www.tiktok.com/@yahoofinance?lang=en
Facebook: www.facebook.com/yahoofinance/
LinkedIn: www.linkedin.com/company/yahoo-finance